The article examines how policies and practices at community hospitals prevent many cancer patients from entering into lifesaving drug trials. To address this issue, the author suggests that local physicians be given smaller workloads and patient counts as well as for improvements to be made to patient-trial matching technology.
© 2001-2024 Fundación Dialnet · Todos los derechos reservados